Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended to include the substance double stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus for bees while establishing the absence of the need to establish a MRL, applicable to honey.

Following discussion on appropriate measures and concerns expressed as regards possible risks for infants and young children following acute dietary intake exposure, the Commission asked EFSA for a complementary scientific statement on nitrates in vegetables, whereby the possible risks for infants and young children related to the presence of nitrates in fresh vegetables are assessed in more detail, also considering the acute dietary intake, taking into account recent occurrence data on the presence of nitrates in vegetables, more detailed consumption data of vegetables by infants and young children and the possibility of the establishme ...[+++]nt of slightly higher than the current maximum levels for nitrates in leafy vegetables.

Following discussion on appropriate measures and concerns expressed as regards possible risks for infants and young children following acute dietary intake exposure, the Commission asked EFSA for a complementary scientific statement on nitrates in vegetables, whereby the possible risks for infants and young children related to the presence of nitrates in fresh vegetables are assessed in more detail, also considering the acute dietary intake, taking into account recent occurrence data on the presence of nitrates in vegetables, more detailed consumption data of vegetables by infants and young children and the possibility of the establishme ...[+++]nt of slightly higher than the current maximum levels for nitrates in leafy vegetables.

Recent decades have seen a growing prevalence of so called ‘vertical’ funds targeting specific diseases - AIDS, Tuberculosis, Malaria, Poliomyelitis, etc. siphoning resources away from international aid and private initiatives.

The problem of the lack of reliable, accurate data to track MDG progress is particularly acute in Africa.

Moreover, we need to acknowledge that, for certain specific purposes, it is still necessary to use subhuman primates today. It is necessary for the purposes of assessing the effectiveness and safety of Aids vaccines – every year, another two million people die – for the production of monoclonal antibody vaccines to fight diseases such as cancer, polio, tuberculosis or malaria, and where there are no alternative methods in existence.